N-(1-Cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide → N-Cyclopropyl-4-oxazol-5-yl-N-[1-(3-pyridin-3-yl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-benzamide

Participants

Role	Name	HCID	Charge
Reactant	N-(1-Cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide	HCID 86678209	—
Reactant	HCID 178513339	HCID 178513339	—
Product	N-Cyclopropyl-4-oxazol-5-yl-N-[1-(3-pyridin-3-yl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-benzamide	HCID 68351872	—

Reaction Steps

The title compound is prepared from N-(1-cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide and N-hydroxy-nicotinamidine following a procedure analogous to that described in Example 1. LC (method 6): tR=1.57 min; Mass spectrum (ESI+): m/z=457 [M+H]+.

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US08822471B2
Source dataset	uspto-grants-2014_09
ORD ID	ord-ed2ab07251054b7c87522fd99a9dee05
Source note	uspto-grants-2014_09